-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the afternoon of November 30th, Shanghai Sunshine Pharmaceutical Purchasing Network issued an announcement stating that in accordance with the "National Drug Centralized Purchasing Document (Insulin Special) (GY-YD2021-3)", the Joint Purchasing Office has carried out special centralized purchasing of insulin.
The results (see attachment for details), the specific implementation date will be announced separately
.
The results (see attachment for details), the specific implementation date will be announced separately
.
In terms of the number of winning products, Novo Nordisk has 7 products, Eli Lilly has 5 products, Poland Baitong has 3 products, Sanofi has 2 products, Ganli Pharmaceutical has 6 products, United Laboratories has 6 products, and Tonghua Dongbao.
There are five, Hefei Tianmai has three, Dongyang Sun Pharmaceutical has two, Wanbang Biochemical has two, and Hisun Pharmaceutical has one
.
There are five, Hefei Tianmai has three, Dongyang Sun Pharmaceutical has two, Wanbang Biochemical has two, and Hisun Pharmaceutical has one
.
Attachment 1 : Selection result table of national centralized drug procurement (insulin special item)
Attachment 2: List of products to be supplied after the selection in the national centralized drug procurement (insulin special item)
On the afternoon of November 30th, Shanghai Sunshine Pharmaceutical Purchasing Network issued an announcement stating that in accordance with the "National Drug Centralized Purchasing Document (Insulin Special) (GY-YD2021-3)", the Joint Purchasing Office has carried out special centralized purchasing of insulin.
The results (see attachment for details), the specific implementation date will be announced separately
.
The results (see attachment for details), the specific implementation date will be announced separately
.
In terms of the number of winning products, Novo Nordisk has 7 products, Eli Lilly has 5 products, Poland Baitong has 3 products, Sanofi has 2 products, Ganli Pharmaceutical has 6 products, United Laboratories has 6 products, and Tonghua Dongbao.
There are five, Hefei Tianmai has three, Dongyang Sun Pharmaceutical has two, Wanbang Biochemical has two, and Hisun Pharmaceutical has one
.
There are five, Hefei Tianmai has three, Dongyang Sun Pharmaceutical has two, Wanbang Biochemical has two, and Hisun Pharmaceutical has one
.
Attachment 1 : Selection result table of national centralized drug procurement (insulin special item)
Attachment 2: List of products to be supplied after the selection in the national centralized drug procurement (insulin special item)
On the afternoon of November 30th, Shanghai Sunshine Pharmaceutical Purchasing Network issued an announcement stating that in accordance with the "National Drug Centralized Purchasing Document (Insulin Special) (GY-YD2021-3)", the Joint Purchasing Office has carried out special centralized purchasing of insulin.
The results (see attachment for details), the specific implementation date will be announced separately
.
The results (see attachment for details), the specific implementation date will be announced separately
.
In terms of the number of winning products, Novo Nordisk has 7 products, Eli Lilly has 5 products, Poland Baitong has 3 products, Sanofi has 2 products, Ganli Pharmaceutical has 6 products, United Laboratories has 6 products, and Tonghua Dongbao.
There are five, Hefei Tianmai has three, Dongyang Sun Pharmaceutical has two, Wanbang Biochemical has two, and Hisun Pharmaceutical has one
.
There are five, Hefei Tianmai has three, Dongyang Sun Pharmaceutical has two, Wanbang Biochemical has two, and Hisun Pharmaceutical has one
.
Attachment 1 : Selection result table of national centralized drug procurement (insulin special item)
Attachment 1 : National centralized drug procurement (insulin specific) selected result table National centralized drug procurement (insulin specific) selected result table National centralized drug procurement (insulin specific) selected Attachment 2: List of products to be supplied after the selection in the national centralized drug procurement (insulin special item)
List of products supplied after the selection of the national centralized drug procurement (Insulin special) List of products supplied after the selection of the national centralized drug procurement (Insulin special) 
